Microbot Medical Inc. Form 8-K Summary
Business Context and Reporting Period
Microbot Medical Inc. (NASDAQ: MBOT) filed a Current Report on Form 8-K on August 11, 2026. The filing serves as a Regulation FD disclosure to announce the release of the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2026.
Key Financial Metrics
This Form 8-K is a procedural filing and does not contain specific financial data. The document states that financial highlights for the second quarter ended June 30, 2026, are provided in the attached press release (Exhibit 99.1), which is not included in the source text. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not available in this filing.
Material Changes
The filing does not detail specific material changes in financial performance or operations. It solely references the availability of the Q2 2026 results in the accompanying press release.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors. It includes a standard disclaimer stating that the information is furnished and not deemed filed for purposes of Section 18 of the Exchange Act, and the Company makes no admission as to the materiality of the information.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for specific Q2 2026 financial results.
- Access the full Form 10-Q for the period ended June 30, 2026, for detailed financial statements and MD&A.
- Verify the trading status of Common Stock on the NASDAQ Capital Market.
- Confirm the Company's status as an Emerging Growth Company (indicated as unchecked in this filing).